atopica logo

ATOPICA® (cyclosporine capsules) USP MODIFIED

Captar Logo

Capstar® (nitenpyram)

Clomicalm Logo 4C 2016

Clomicalm® (clomipramine hydrochloride)

Comfortis Logo

Comfortis® (spinosad)

Deramaxx logo

Deramaxx® (deracoxib)

Duramune Logp

Duramune®, Duramune Lyme® and LeptoVax®4

Galliprant Logo

Galliprant® (grapiprant tablets)

Interceptor® (milbemycin oxime)

Interceptor Plus Logo

Interceptor® Plus (milbemycin oxime/praziquantel)

Onsior logo

Onsior® Tablets for Dogs (robenacoxib)

onsior logo

Onsior® Injection (robenacoxib)

Osurnia® (florfenicol, terbinafine, betamethasone acetate)

PARASTAR Logo

Parastar® for Dogs

ParastarPLUS Logo

Parastar® Plus (fipronil/cyphenothrin)

Percorten-V Logo

Percorten®-V (desoxycorticosterone pivalate injectable suspension)

Placeholder until correct image

Rabvac®

Surolan Logo

Surolan® (miconazole nitrate, polymyxin B sulfate, prednisolone acetate)

Trifexis logo

Trifexis® (spinosad + milbemycin oxime)

Ultra Duramune logo

ULTRA™ Duramune®

Vetspon logo

Vetspon

Zobuxa logo

Zobuxa® (enrofloxacin)

Zobuxa logo
Zobuxa® (enrofloxacin)

Value without compromise

Main benefits vs. Baytril® (enrofloxacin) Taste Tabs®:

  • Same efficacy and safety profile at a lower cost
  • Smaller tablet sizes*, which makes it easier to administer
  • Additional tablet size (272 mg), for better dosing large dogs

*Smaller tablets sizes are 136 mg (50 tablets), 22.7 mg (100 tablets), 22.7 mg (500 tablets) and 68 mg (50 tablets). Baytril is not available as a 272 mg tablet.
Baytril and Taste Tabs are registered trademarks of Bayer HealthCare, LLC.

Indication

Zobuxa is a flavored antibacterial tablet for dogs and cats, indicated for use in dogs and cats for the management of diseases associated with bacteria susceptible to enrofloxacin.

Important Safety Information

Federal law prohibits the extra label use of this drug in food-producing animals. Do not use in dogs or cats known to be hypersensitive to quinolones, or in small and medium breeds of dogs during the rapid growth phase (2–8 months of age). The safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. For use in dogs and cats only. In rare instances, use of this product in cats has been associated with retinal toxicity. Do not exceed 5 mg/kg of body weight per day in cats. Safety in breeding or pregnant cats has not been established. Use with caution in animals with known or suspected Central Nervous System (CNS) disorders. Please see product insert for full prescribing information.



Zobuxa is a trademark of Eli Lilly and Company or its affiliates.